false
0001838987
0001838987
2026-01-27
2026-01-27
0001838987
SPWR:CommonStockParValue0.0001PerShareMember
2026-01-27
2026-01-27
0001838987
SPWR:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2026-01-27
2026-01-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 27, 2026
SunPower Inc.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-40117 |
|
93-2279786 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
| 45700 Northport Loop East, Fremont, CA |
|
94538 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (510) 270-2507
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
SPWR |
|
The Nasdaq Global Market |
| |
|
|
|
|
| Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share |
|
SPWRW |
|
The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 1.01. Entry into a Material Definitive Agreement.
Standby Equity Purchase Agreement and Related
Transactions
On January 27, 2026 (the “Effective Date”),
SunPower Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) with
YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”). Capitalized terms used herein, but not otherwise
defined, have the meaning given to such terms in the SEPA, a copy of which is filed herewith as Exhibit 10.1.
Pursuant to the SEPA, the Investor will advance
to the Company, subject to the satisfaction of certain conditions set forth in the SEPA, up to $20 million principal amount (the “Pre-Paid
Advances”), which will be evidenced by convertible promissory notes (the “Promissory Notes”), in two tranches.
The Promissory Notes will accrue interest on the outstanding principal balance at an annual rate equal to 0%, which will increase to an
annual rate of 18% upon the occurrence of an Event of Default (as defined in the Promissory Notes) for so long as such event remains uncured.
The Promissory Notes will mature on January 27, 2027, which may be extended at the option of the Investor.
The Promissory Notes are convertible into shares
of the Company’s common stock, $0.0001 par value per share (the “Common Stock”),
at a conversion price equal to the lower of (i) a price per share equal to 125% of the volume weighted average price (“VWAP”)
of the Common Stock on the trading day prior to the issuance date of each Promissory Note, or (ii) 93% of the lowest daily VWAP during
the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in
effect, subject to adjustment from time to time in accordance with the terms contained in the Promissory Notes).
The first tranche of the Pre-Paid Advance was
disbursed on January 27, 2026 in the principal amount of $1.9 million. Subject to the conditions set forth in the SEPA, a second tranche
of the Pre-Paid Advance in a principal amount of up to $18.1 million may be advanced on the second trading day after the initial registration
statement relating to the resale of the shares of the Company’s Common Stock issuable upon conversion of the Promissory Notes first
becomes effective.
At the closing of each tranche of the Pre-Paid
Advances, the Investor will advance to the Company the principal amount of the applicable tranche of the Pre-Paid Advance, less a discount
in the amount equal to 10% of the principal amount of such tranche of the Pre-Paid Advance netted from the purchase price due.
Pursuant to the SEPA, and upon the satisfaction
of the conditions to the Investor’s purchase obligation set forth in the SEPA, including the registration of shares of Common Stock
issuable pursuant to the SEPA for resale, the Company will have the right, from time to time, until January 27, 2029 (unless the SEPA
is terminated earlier), to require the Investor to purchase up to $25 million of shares of Common Stock (the “Commitment Amount”),
subject to certain limitations and conditions set forth in the SEPA, by delivering written notice to the Investor (an “Advance
Notice”).
If there is no balance outstanding under the Promissory
Notes, the Company may, in its sole discretion, select the amount of the Advance that it desires to issue and sell to the Investor in
each Advance Notice, subject to a maximum limit equal to 100% of the average of the daily volume traded of our common stock on the Nasdaq
for the five consecutive trading days immediately preceding the delivery of an Advance Notice (the “Maximum Advance Amount”).
If there is a balance outstanding under the Promissory Notes, we may only submit an Advance Notice (i) if an Amortization Event (as defined
in the Promissory Notes) has occurred and our obligation to make prepayments under the Promissory Notes has not ceased, and (ii) the aggregate
purchase price owed to us from such Advances (the “Advance Proceeds”) will be paid by the Investor by offsetting the
amount of the Advance Proceeds against an equal amount outstanding under the Promissory Notes. Pursuant to an Advance Notice, the shares
will be issued and sold to the Investor at a per share price equal to, at our election as specified in the relevant Advance Notice: (i)
96% of the market price for any period beginning at such time that the Company of receives confirmation of receipt of such Advance Notice
by the Investor and ending on 4:00 p.m. Eastern Time on the date of the applicable Advance Notice, or (ii) 97% of the market price for
the three consecutive trading days commencing on the day such Advance Notice is deemed delivered pursuant to the terms of the SEPA.
The Company paid the Investor a structuring and
due diligence fee of $50,000 and agreed to issued to the investor 175,000 shares of Common Stock within three days of the Effective Date,
as a commitment fee (the “Commitment Shares”).
Under the applicable Nasdaq listing rules and
pursuant to the SEPA, in no event may the Company issue or sell to the Investor shares of Common Stock in excess of 22,381,878 shares
of Common Stock (the “Exchange Cap”), which is approximately 19.99% of the shares of Common Stock outstanding immediately
prior to the Effective Date, unless the Company obtains stockholder approval to issue shares of Common Stock in excess of the Exchange
Cap.
In addition, the Company may not issue or sell
any shares of Common Stock to the Investor under the SEPA or under the Promissory Notes, which, when aggregated with all other shares
of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Securities
Exchange Act of 1934, as amended, and Rule 13d-3 promulgated thereunder), would result in the Investor and its affiliates beneficially
owning more than 4.99% of the then-outstanding shares of Common Stock.
The SEPA will automatically terminate on the earliest
to occur of (i) January 27, 2029 or (ii) the date on which the Investor has purchased from the Company under the SEPA the Commitment Amount
in full. The Company may terminate the SEPA at any time upon five trading days’ prior written notice to the Investor, provided that
there are no outstanding Advance Notices under which the Company is yet to issue Common Stock, there are no amounts outstanding under
the Promissory Notes, and provided that the Company has paid all amounts owed to the Investor pursuant to the SEPA. The Company and the
Investor may also agree to terminate the SEPA by mutual written consent. Neither the Company nor the Investor may assign or transfer their
respective rights and obligations under the SEPA, and no provision of the SEPA may be modified or waived by the Company or the Investor
other than by an instrument in writing signed by both parties.
The SEPA contains customary representations, warranties,
conditions, and indemnification obligations of the parties. The representations, warranties, and covenants contained in the SEPA were
made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may
be subject to limitations agreed upon by the parties.
In connection with the SEPA, the Company entered
into a registration rights agreement (the “Registration Rights Agreement”) with the Investor, pursuant to which the
Company agreed to file a registration statement registering the resale of the Common Stock underlying the Promissory Notes, the Commitment
Shares and, if applicable and subject to the Company’s discretion, additional Advances pursuant to the SEPA.
The foregoing description of (i) the SEPA, (ii)
the Promissory Notes, and (iii) the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by
reference to the full text of (a) the SEPA, which is attached hereto as Exhibit 10.1, (b) the Promissory Note evidencing the first tranche
of the Pre-Paid Advance, which is attached hereto as Exhibit 10.2, and (c) the Registration Rights Agreement, which is attached hereto
as Exhibit 10.3, respectively, and each are incorporated herein by reference.
12.0% Convertible Promissory Note
On January 29, 2026, the Company issued a convertible
promissory note in the original principal amount of $3,300,000 (the “January 2026 12% Note”) to a trust controlled
by Thurman J. Rodgers, the Company’s Chief Executive Officer and Executive Chairman.
The January 2026 12% Note bears a 12% interest
rate. The January 2026 12% Note is a general unsecured obligation of the Company and will mature on July 1, 2029, unless earlier converted,
redeemed or repurchased. Interest on the January 2026 12% Note will be payable semiannually in arrears on January 1 and July 1 of each
year, beginning on July 1, 2026. The January 2026 12% Note is convertible at the option of the holder at any time prior to the payment
of the payment of the principal amount of the January 2026 12% Note in full. Upon conversion of the January 2026 12% Note, the Company
will satisfy its conversion obligation by delivering shares of Common Stock and paying cash in respect of any fractional shares.
The conversion rate of the January 2026 12% Note
is initially equal to 540.5405 shares of Common Stock per $1,000 principal amount due under the January 2026 12% Note. The conversion rate
shall be subject to adjustment from time to time pursuant to the terms of the January 2026 12% Note.
The Company may not redeem the January 2026 12%
Note prior to July 5, 2026. The Company may redeem for cash all (but not less than all) of the January 2026 12% Note, at its option, (i)
on or after July 5, 2026 and prior to July 1, 2027, if the last reported sale price of the Common Stock has been at least 150% of the
conversion price for the January 2026 12% Note then in effect and (ii) on or after July 5, 2027 and prior to the maturity date for the
January 2026 12% Note if the last reported sale price of the Common Stock has been at least 130% of the conversion price for the January
2026 12% Note then in effect, in each case of (i) and (ii), for at least 20 trading days (whether or not consecutive) during any 30 consecutive
trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the
date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the January 2026
12% Note, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the January
2026 12% Note.
If the Company undergoes a change of control (as
defined in the January 2026 12% Note), then, subject to certain conditions and except as described in the January 2026 12% Note, the holder
may require the Company to redeem for cash all (but not less than all) of January 2026 12% Note at a price equal to 100% of the principal
amount of the January 2026 12% Note.
The January 2026 12% Note sets forth certain events
of default after which the January 2026 12% Note may be declared immediately due and payable and sets forth certain types of bankruptcy
or insolvency events of default involving the Company after which the January 2026 12% Note becomes automatically due and payable. The
following events are considered “events of default” under the January 2026 12% Note:
| ● | (i) any default in any payment of principal amount, change of control redemption amount or redemption
price on the January 2026 12% Note when due and payable or (ii) any default in the payment of interest when due and payable and such failure
to pay is not cured within 30 calendar days from the occurrence thereof; |
| ● | failure to deliver, when required by the January 2026 12% Note, a change of control notice or notice of
a change of control or an organic change; |
| ● | default in the Company’s obligation to convert the January 2026 12% Note upon exercise of the conversion
right with respect to the January 2026 12% Note if not cured within five business days after its occurrence; |
| ● | the Company, any subsidiary of the Company or any of their respective affiliates fails to pay principal
when due (whether at stated maturity or otherwise) or an uncured default exists that results in the acceleration of maturity of any indebtedness
of the Company, any subsidiary of the Company or any of their respective affiliates in an aggregate amount in excess of $10,000,000 (or
its foreign currency equivalent), unless such indebtedness is discharged, or such acceleration is rescinded, stayed or annulled, within
any applicable cure period set forth in the relevant agreement or instrument; |
| ● | one or more final non-appealable judgments for the payment of money in any aggregate amount in excess
of $10,000,000 shall be rendered against the Company, any subsidiary of the Company or any of their respective affiliates, or any combination
thereof, and the same shall remain undischarged for a period of 60 days during which execution shall not be effectively stayed, or any
action shall be legally taken by a judgment creditor to levy upon assets or properties of the Company, any subsidiary of the Company or
any of their respective affiliates to enforce any such judgment; and |
| ● | certain events of bankruptcy, insolvency or reorganization of the Company. |
If certain bankruptcy
and insolvency-related events of default occur with respect to the Company, the principal of, and accrued and unpaid interest, if any,
on, the January 2026 12% Note shall automatically become due and payable. If an event of default with respect to the January 2026 12%
Note, other than certain bankruptcy and insolvency-related events of default with respect to the Company, occurs and is continuing, a
holder may at its option declare the January 2026 12% Note to be immediately due and payable.
A copy of the January
2026 12% Note is attached hereto as Exhibit 4.1 and is incorporated herein by reference (and the foregoing description of the January
2026 12% Note is qualified in its entirety by reference to such exhibit).
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above in Item 1.01 of
this Current Report on Form 8-K with respect to the Promissory Notes and the January 2026 12% Note is incorporated by reference herein.
Item 3.02. Unregistered Sales of Equity Securities.
SEPA Transaction
The disclosure set forth above in Item 1.01 of
this Current Report on Form 8-K relating to the issuance of shares of Common Stock to the Investor pursuant to the SEPA, including any
shares to be issued in connection with an Advance Notice, or the Commitment Shares, and relating to the issuance of the Promissory Notes
(and the shares of Common Stock issuable upon conversion of the Promissory Notes), is incorporated by reference herein in its entirety.
The offer and sale of shares of Common Stock and the issuance of the Promissory Notes pursuant to the SEPA was and will be made in reliance
upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”).
January 2026 12% Note
The Company issued the January 2026 12% Note in
reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act. The January 2026 12% Note and the shares
of Common Stock issuable upon conversion of the January 2026 12% Note, if any, have not been registered under the Securities Act and may
not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. To the extent
that any shares of Common Stock are issued upon conversion of the January 2026 12% Note, they will be issued in transactions anticipated
to be exempt from registration under the Securities Act by virtue of Section 3(a)(9) thereof because no commission or other remuneration
is expected to be paid in connection with conversion of the January 2026 12% Note and any resulting issuance of shares of Common Stock.
A maximum of 1,783,783 shares of Common Stock may be issued upon conversion of the $3,300,000 principal amount of the January 2026 12%
Note based on the conversion rate of 540.5405 shares of Common Stock per $1,000 principal amount of the January 2026 12% Note, which is
subject to customary anti-dilution adjustment provisions.
This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any offer, solicitation,
or sale of the securities in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number |
|
Description |
| 4.1 |
|
Convertible Promissory Note dated January 29, 2026. |
| 10.1 |
|
Standby Equity Purchase Agreement, dated January 27, 2026, between SunPower Inc. and YA II PN, LTD.+ * |
| 10.2 |
|
Convertible Promissory Note, dated January 27, 2026,
between SunPower Inc. and YA II PN, LTD. + * |
| 10.3 |
|
Registration Rights Agreement, dated January 27, 2026, between SunPower Inc. and YA II PN, LTD. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| + | Certain of the exhibits and schedules to this exhibit have been
omitted in accordance with Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish a copy of all omitted exhibits
and schedules to the SEC upon its request. |
| * | Portions of this exhibit are redacted in accordance with Item
601(b)(10)(iv) of Regulation S-K. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
SunPower Inc. |
| |
|
| Dated: January 30, 2026 |
By: |
/s/ Thurman J. Rodgers |
| |
|
Thurman J. Rodgers |
| |
|
Chief Executive Officer |
5
